— Know what they know.
Not Investment Advice

VVOS

Vivos Therapeutics, Inc.
1W: -14.9% 1M: -26.0% 3M: -44.4% YTD: -54.9% 1Y: -69.3% 3Y: -86.2% 5Y: -99.4%
$1.14
-0.01 (-0.87%)
After Hours: $1.28 (+0.14, +12.28%)
NASDAQ · Healthcare · Medical - Devices · $6.7M · Alpha Radar Strong Sell · Power 25
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$6.7M
52W Range1.09-7.95
Volume85,750
Avg Volume124,503
Beta7.02
Dividend
Analyst Ratings
4 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOR. Kirk Huntsman
Employees109
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-12-11
Websitevivos.com
9137 Ridgeline Boulevard
Highlands Ranch, CO 80129
US
866 908 4867
About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Recent Insider Trades

NameTypeSharesPriceDate
JOHNSON GREGG C 0 2026-02-04
Skaff Michael C 0 2025-06-09
Skaff Michael C 0 2025-06-09
Skaff Michael C 2,329,886 $2.23 2025-06-09
Skaff Michael C 725,258 $0.00 2025-06-09

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms